BioCentury
ARTICLE | Company News

Cambrex, Zenara Pharma deal

November 15, 2010 8:00 AM UTC

Cambrex acquired 51% of Zenara for $20 million. Cambrex said it will acquire the remaining 49% of the company, which will be renamed Cambrex Zenara, in early 2016. Cambrex said the acquisition will al...